Literature DB >> 27232273

Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency.

Ashley K Koegel1, Inga Hofmann2,3, Kristin Moffitt3,4, Barbara Degar2,3, Christine Duncan2,3, Venée N Tubman2,3.   

Abstract

Patients with GATA2 haploinsufficiency have a significant predisposition to developing cytopenias, unique infectious manifestations, and myelodysplastic syndrome/acute myeloid leukemia (MDS/AML). We report a unique case of a patient who presented with B-cell acute lymphoblastic leukemia (B-ALL) and was subsequently diagnosed with monocytopenia and mycobacterium avium complex (MonoMAC) syndrome/GATA2 haploinsufficiency. The development of MDS/AML in patients with GATA2 haploinsufficiency is well described, however, the development of ALL has not been reported in the literature. ALL may be associated with GATA2 haploinsufficiency. Clinicians should be attuned to the features of the MonoMAC syndrome in patients with ALL that would prompt additional testing and alter treatment.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ALL; MDS; bone marrow failure; congenital (not HIV); immunodeficiency; oncology; pediatric hematology

Mesh:

Substances:

Year:  2016        PMID: 27232273     DOI: 10.1002/pbc.26084

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

Review 1.  GATA factor mutations in hematologic disease.

Authors:  John D Crispino; Marshall S Horwitz
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 2.  Germline GATA2 Mutation and Bone Marrow Failure.

Authors:  Lisa J McReynolds; Katherine R Calvo; Steven M Holland
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

3.  Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.

Authors:  Inga Hofmann; Serine Avagyan; Alyssa Stetson; Dongjing Guo; Hasan Al-Sayegh; Wendy B London; Leslie Lehmann
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-20       Impact factor: 5.742

4.  Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.

Authors:  Edgar Borges de Oliveira-Júnior; Jérémie Rosain; Franck Rapaport; Caroline Deswarte; Antoine Guérin; Sairaj Munavar Sajjath; Yu Jerry Zhou; Stéphane Marot; Claire Lozano; Aurélie Cobat; Laurent Abel; Jean-Laurent Casanova; Carmen Oleaga-Quintas; Lidia Branco; Nuria Fernández-Hidalgo; Dukhee Betty Lew; Anne-Sophie Brunel; Caroline Thomas; Elise Launay; Andrés Augusto Arias; Alexis Cuffel; Vanesa Cunill Monjo; Anna-Lena Neehus; Laura Marques; Manon Roynard; Marcela Moncada-Vélez; Bengü Gerçeker; Roger Colobran; Marie-Gabrielle Vigué; Gabriela Lopez-Herrera; Laura Berron-Ruiz; Nora Hilda Segura Méndez; Patricia O'Farrill Romanillos; Tom Le Voyer; Anne Puel; Christine Bellanné-Chantelot; Kacy A Ramirez; Lazaro Lorenzo-Diaz; Noé Ramirez Alejo; Rebeca Pérez de Diego; Antonio Condino-Neto; Fethi Mellouli; Carlos Rodriguez-Gallego; Torsten Witte; José Franco Restrepo; Mariana Jobim; Stéphanie Boisson-Dupuis; Eric Jeziorski; Claire Fieschi; Guillaume Vogt; Jean Donadieu; Marlène Pasquet; Julia Vasconcelos; Fatma Omur Ardeniz; Mónica Martínez-Gallo; Regis A Campos; Luiz Fernando Jobim; Rubén Martínez-Barricarte; Kang Liu; Jacinta Bustamante
Journal:  J Clin Immunol       Date:  2021-01-08       Impact factor: 8.317

5.  Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment.

Authors:  Nikita Raje; Brenda L Snyder; David A Hill; Jenna L Streicher; Kate E Sullivan
Journal:  Ann Allergy Asthma Immunol       Date:  2018-03-19       Impact factor: 6.347

Review 6.  Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017.

Authors:  Cristiane de Jesus Nunes-Santos; Sergio D Rosenzweig
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

7.  Conditionally pathogenic genetic variants of a hematopoietic disease-suppressing enhancer.

Authors:  Alexandra A Soukup; Daniel R Matson; Peng Liu; Kirby D Johnson; Emery H Bresnick
Journal:  Sci Adv       Date:  2021-12-10       Impact factor: 14.136

8.  Case report: Successful allogeneic stem cell transplantation in a child with novel GATA2 defect associated B-cell acute lymphoblastic leukemia.

Authors:  Edyta Heropolitańska-Pliszka; Barbara Piątosa; Anna Szmydki-Baran; Karolina Kuczborska; Karolina Miarka-Walczyk; Agata Pastorczak; Wojciech Młynarski; Łukasz Sędek; Tomasz Szczepański; Marek Ussowicz
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

Review 9.  GATA2 +9.5 enhancer: from principles of hematopoiesis to genetic diagnosis in precision medicine.

Authors:  Alexandra A Soukup; Emery H Bresnick
Journal:  Curr Opin Hematol       Date:  2020-05       Impact factor: 3.218

10.  Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients.

Authors:  Jean Donadieu; Marie Lamant; Claire Fieschi; Flore Sicre de Fontbrune; Aurélie Caye; Marie Ouachee; Blandine Beaupain; Jacinta Bustamante; Hélène A Poirel; Bertrand Isidor; Eric Van Den Neste; Antoine Neel; Stanislas Nimubona; Fabienne Toutain; Vincent Barlogis; Nicolas Schleinitz; Thierry Leblanc; Pierre Rohrlich; Felipe Suarez; Dana Ranta; Wadih Abou Chahla; Bénédicte Bruno; Louis Terriou; Sylvie Francois; Bruno Lioure; Guido Ahle; Françoise Bachelerie; Claude Preudhomme; Eric Delabesse; Hélène Cave; Christine Bellanné-Chantelot; Marlène Pasquet
Journal:  Haematologica       Date:  2018-05-03       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.